Summary:
- The article discusses recent clinical research identifying a specific biological pathway—involving the protein SHANK3—that plays a critical role in the synaptic development associated with autism spectrum disorder.
- Researchers demonstrate that pharmacological intervention targeting this pathway in animal models has shown potential in reversing certain social and behavioral deficits, offering a foundational basis for future human clinical trials and precision medicine approaches.